Elexacaftor Tezacaftor And Ivacaftor + Telithromycin Interaction
Majorinteraction on record
Description
Strong CYP3A inhibitor expected to significantly increase TRIKAFTA component exposures. TRIKAFTA dosage reduction required.
Mechanism
CYP3A inhibition
Source: NLP:elexacaftor, tezacaftor, and ivacaftor